Status:
COMPLETED
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
Lead Sponsor:
Daiichi Sankyo
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
Eligibility Criteria
Inclusion
- Male or female patients
- 18 years of age or older (20% equal to or older than 65 years)
- With mild to severe hypertension defined as seated diastolic blood pressure of 95-120 mmHg while off any hypertensive medication
Exclusion
- Patients should not have serious concomitant conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patients
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
1900 Patients enrolled
Trial Details
Trial ID
NCT00185133
Start Date
May 1 2005
End Date
January 1 2007
Last Update
December 24 2018
Active Locations (139)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Huntsville, Alabama, United States
3
Mobile, Alabama, United States
4
Muscle Shoals, Alabama, United States